Report overview
Demand for transplant diagnostic products is expected to increase, mainly due to factors such as increased public-private partnership funding for targeted research activities, increased burden of infectious diseases, increased number of transplant procedures, and technological advancements in the field of transplant diagnostics. The market segment by technology is divided into molecular and non-molecular analytical technologies. The field of molecular analysis technology has the largest market share. A large part of this part can be attributed to the benefits of molecular detection, such as short turnaround time, high program efficiency, research on multiple samples, and real-time sample analysis.
This report contains market size and forecasts of Organ Transplant Diagnostics in Global, including the following market information:
Global Organ Transplant Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Organ Transplant Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Assay Technologies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Organ Transplant Diagnostics include QIAGEN NV, Thermo Fisher Scientific, BioM?rieuxSA, CareDx, Luminex Corporation, Dickinson and Company and Biofortuna, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Organ Transplant Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Organ Transplant Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Organ Transplant Diagnostics Market Segment Percentages, by Type, 2021 (%)
Molecular Assay Technologies
Non-molecular Assay Technologies
Global Organ Transplant Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Organ Transplant Diagnostics Market Segment Percentages, by Application, 2021 (%)
Independent Reference Laboratories
Hospitals and Transplant Centers
Research Laboratories and Academic Institutes
Global Organ Transplant Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Organ Transplant Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Organ Transplant Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Organ Transplant Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
QIAGEN NV
Thermo Fisher Scientific
BioM?rieuxSA
CareDx
Luminex Corporation
Dickinson and Company
Biofortuna
